MRVI - BofA ups Maravai to buy; cites compelling' valuation takeout potential
2023-12-12 12:34:39 ET
More on Maravai LifeSciences Holdings
- Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2023 Earnings Call Transcript
- Maravai LifeSciences Holdings, Inc. 2023 Q3 - Results - Earnings Call Presentation
- Maravai LifeSciences: Falling Victim To COVID Boom And Bust
- Maravai hits 52-week low after Q3 miss, cost cutting
- Maravai LifeSciences Holdings GAAP EPS of -$0.05 misses by $0.04, revenue of $66.9M misses by $8.62M
For further details see:
BofA ups Maravai to buy; cites "compelling' valuation, takeout potential